TENX

Tenax Therapeutics Stock Analysis

AI Rating

Good
  • Quality4/10
  • Growth↑ 8/10
  • Momentum↑ 9/10
Tenax Therapeutics sales and earnings growth
TENX Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 95.66%
  • FCF Y/Y↓ -107.98%
Tenax Therapeutics gross and profit margin trends
TENX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 1681.90%
Tenax Therapeutics net debt vs free cash flow
TENX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -93175.2

Tenax Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗